Use of C-reactive protein to guide the antibiotic therapy in hospitalized patients: a systematic review and meta-analysis
Authors:
Open Access
- 3 May 2023
- journal article
- review article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 23 (1) , 1-11
Abstract
Background: C-reactive protein (CRP) is an inflammatory protein used in clinical practice to identify and monitor inflammatory and infectious processes. Recent data suggest CRP might be useful in guiding antibiotic therapy discontinuation among critical care patients. This meta-analysis analyzed the benefits and risks of CRP-guided protocols to guide antibiotic therapy in hospitalized patients in comparison with standard treatment. Methods: Studies were searched in four databases: CENTRAL, Medline, Embase and LILACS. The search was performed until Jan 25th, 2023. The reference lists of the articles retrieved and related review studies were hand-screened to find eligible trials that might have been missed. Primary endpoints included the duration of antibiotic therapy for the index episode of infection. The secondary endpoint was the all-cause hospital mortality and infection relapses. The risk of bias was evaluated using the Cochrane Risk of Bias 2.0 tool. Random effects were used to pool the mean differences and odds ratio of individual studies. The protocol was registered in PROSPERO (CRD42021259977). Results: The search strategy retrieved 5209 titles, out of which three studies met the eligibility criteria and were included in this meta-analysis. 727 adult patients were analyzed, of whom 278 were included in the intervention group and 449 were included in the control group. 55,7% of all patients were women. Meta-analysis indicated that experimental groups (CRP-guided) had a lower duration of antibiotic therapy (days) [MMD = -1.82, 95%IC -3.23; -0.40]; with no difference in mortality [OR = 1.19 95%IC 0.67–2.12] or in the occurrence of infection relapse [OR = 3.21 95%IC 0.85–12.05]. Conclusion: The use of CRP-guided protocol reduces the total amount of time required for antibiotic therapy when compared to standard protocols of treatment in hospitalized patients with acute bacterial infection. We did not observe statistical differences regarding mortality and infection relapse rates.Keywords
All Related Versions
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (302153/2019-5, 311759/2020-3)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (002345/2019)
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais (CDS-APQ-02541-17)
- Secretaria de Educação Superior do Ministério da Educação (Grant 04/2020)
This publication has 23 references indexed in Scilit:
- Point-of-care C-reactive protein testing to reduce inappropriate use of antibiotics for non-severe acute respiratory infections in Vietnamese primary health care: a randomised controlled trialThe Lancet Global Health, 2016
- Sepsis biomarkersClinica Chimica Acta, 2015
- Procalcitonin Versus C-Reactive Protein for Guiding Antibiotic Therapy in SepsisCritical Care Medicine, 2013
- Patterns of c-reactive protein RATIO response in severe community-acquired pneumonia: a cohort studyCritical Care, 2012
- C-reactive protein as a marker of ventilator-associated pneumonia resolution: a pilot studyEuropean Respiratory Journal, 2005
- Serum Procalcitonin and C-Reactive Protein Levels as Markers of Bacterial Infection: A Systematic Review and Meta-analysisClinical Infectious Diseases, 2004
- C-reactive protein: a valuable marker of sepsisIntensive Care Medicine, 2002
- Human C-reactive protein: expression, structure, and functionMolecular Immunology, 2001
- Potential clinical applications of c‐reactive proteinJournal of Clinical Laboratory Analysis, 1990
- Specificity of C-Reactive Protein for Choline Phosphate Residues of Pneumococcal C-PolysaccharideExperimental Biology and Medicine, 1971